Navigation Links
Novavax Announces Preclinical Data for Respiratory Syncytial Virus Vaccine Candidate
Date:12/8/2008

rially from the results discussed in the forward-looking statements or historical experience include risks relating to the early stage of Novavax's product candidates under development; current results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine that we may develop; further testing is required before regulatory approval can be applied for and the FDA may not approve a vaccine even if further trial results are similar to those disclosed previously by the company; uncertainties relating to clinical trials; dependence on the efforts of third parties; competition for clinical resources and patient enrollment from drug candidates in development by other companies with greater resources and visibility; and risks that we may lack the financial resources and access to capital to fund our operations including further clinical trials. Further information on the factors and risks that could affect Novavax's business, financial conditions and results of operations, is contained in Novavax's filings with the U.S. Securities and Exchange Commission, which are available at http://www.sec.gov. These forward-looking statements speak only as of the date of this press release, and Novavax assumes no duty to update forward-looking statements.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Novavax CEO to Present at ACUMENBioFins 9th Annual Healthcare Conference
2. Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs
3. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
4. Novavax Announces Preclinical Results for Seasonal Influenza Vaccine Program
5. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
6. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
7. Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate
8. Novavax Completes Enrollment in Phase I/IIa Pandemic Influenza Vaccine Clinical Trial
9. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
10. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
11. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Levi & Korsinsky announces it has commenced an ... concerning possible violations of federal securities laws. The investigation ... with its study of the drug OHR-102. To obtain ... Joseph E. Levi, Esq. either via email ... 363-7500, toll-free: (877) 363-5972. Levi & Korsinsky ...
(Date:3/27/2015)... , March 27, 2015  Holographic Optical Technologies of ... field of holographic medical imaging, is entering the world ... campaign. Launching on April 20 th , 2015, the ... Pro. The 8-inch and 22-inch displays will allow consumers ... the first time. In addition to the two displays, ...
(Date:3/27/2015)... -- A new report from Kalorama Information says that other ... Chile , Colombia and ... firms.  The healthcare research firm said that while ... Latin American continent with a population of over 200 million ... the country,s regional economic clout does not necessarily ensure its ...
Breaking Medicine Technology:Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 2Holographic Optical Technologies brings cutting-edge holograms to consumer market through upcoming Kickstarter campaign 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... Calif., Feb. 2 InterMune, Inc.,(Nasdaq: ITMN ... its Phase 3,CAPACITY program of pirfenidone in idiopathic pulmonary ... InterMune will conduct a conference,call and webcast, with ... at 8:00 a.m. EST (5:00 a.m. PST) on Tuesday,February ...
... ability of human-animal hybrids to generate stem cells ... (OTC Pink Sheets: ACTC) and its collaborators reported today ... extensively reprogram adult human cells. The research, which appears ... and Stem Cells (Editor-in-Chief: Sir Ian Wilmut; published ...
Cached Medicine Technology:InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5
(Date:3/27/2015)... 27, 2015 Ticket Down is a reputable source ... 2015. After a phenomenal and highly successful live tour last ... going out on tour again in 2015 and they will be ... on April 29th in New York City at the cozy Beacon ... Theatre on May 10th. , Fans of the hit show can ...
(Date:3/27/2015)... 27, 2015 According to a recently ... the plate and screw market in Europe is in ... plate and screw segment. Price decreases are being seen ... almost 50% of the total European trauma device market, ... total market value, year after year. , “Such ...
(Date:3/27/2015)... March 27, 2015 The report “CountryFocus: ... essential source of information on and analysis of the ... population of the US in 2013 amounted to 316.1 ... (CAGR) of 0.8% from 2008. The country’s increasingly elderly ... diseases will help to boost the growth of the ...
(Date:3/27/2015)... Diego, CA (PRWEB) March 27, 2015 ... launch its Protect Our Children (POC) NOW! vitamin D ... the Medical University of South Carolina (MUSC), and will ... will be available at no cost to a minimum ... gestation who live within these two service areas. The ...
(Date:3/27/2015)... 27, 2015 Trail mix is the perfect, ... on weekend hikes and during the game! It’s portable, lightweight ... is proud to introduce a new line of specialty trail ... rich and flavorful selections packed with nutritious, 100% all natural ... and grains that add protein and fiber to your diet ...
Breaking Medicine News(10 mins):Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 2Health News:Titanium Trauma Treatment Devices in Europe Becoming More Affordable, Decreasing Market Value: Group Purchasing Further Eroding Selling Prices 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 2Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 3Health News:US Pharmaceutical Market worth $548.4 billion by 2020 Says a New Report Available at RnRMarketResearch.com 4Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 2Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 3Health News:GrassrootsHealth Moves Vitamin D into Practice with Pregnant Women 4Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2
... study in the September 27 issue of JAMA says that ... the risk of reinfections.// Trachoma is an infectious disease where ... reported that 15 percent of all blindness was caused by ... cataract., ,At that time, the WHO estimated that 146 ...
... a condom that plays music during sex, Korrespondent magazine ... control device as a novelty, and as an aid ... miniature loudspeaker and motion sensor implanted in the condom's ... sex. ,The condom's main limitation is primitive ...
... for infecting cornea cells that may also explain how it ... at the University of Illinois at Chicago College of Medicine. ... of the Journal of Cell Biology. ,Both strains ... cold sores on the mouth, and HSV-2, genital herpes -- ...
... the Johns Hopkins University and other institutions have developed ... Lynch syndrome// , which predisposes families to develop colorectal ... individual’s detailed family history of colorectal and endometrial cancer, ... themselves—in the form of tumors. It can assess a ...
... ?4 million cash boost to fight the spread of the deadly ... towards stemming Scotland's high rates of the infection as well as ... been estimated that about 20,000 people have been infected with Hepatitis ... among Scotland's drug users - in NHS Greater Glasgow and Clyde. ...
... proposed by the FDA for the anti-angiogenic colorectal-cancer drug ... posterior leukoencephalopathy syndrome in its warning.// ,Genentech, ... has been reported or confirmed in less than 0.1% ... ,The Adverse Reactions and Dosage and Administration ...
Cached Medicine News:Health News:Blindness And Trachoma 2Health News:Herpes Infects Cornea, Evades Immune Cells 2Health News:Model Predicts Colon Cancer Inheritable Genetic Defects 2Health News:Scotland’s Fight against Hepatitis C Boosted by ? 2Health News:Warning on Avastin Updated 2
Lytec Medical 2004 practice management software is designed to help you more effectively manage your accounts receivable as well as track authorizations and inventory. Lytec Medical XE provides outst...
PremierEdge™ Stab Knives - 30°....
DCR Set, Angled....
... Leica CM3050 S Cryostat Family ... excellent safety standards for practically ... The Leica CM3050 S is ... all cryosectioning research applications and ...
Medicine Products: